Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	G-protein beta/gamma-subunit complex binding	GNA11 GNAI3 GNAL GNAQ GNAT2	8.06e-09	25	57	5	GO:0031683
GeneOntologyMolecularFunction	activin receptor activity	TGFBR1 ACVR2A ACVR2B	1.83e-06	9	57	3	GO:0017002
GeneOntologyMolecularFunction	activin binding	TGFBR1 ACVR2A ACVR2B	4.76e-06	12	57	3	GO:0048185
GeneOntologyMolecularFunction	transmembrane receptor protein serine/threonine kinase activity	TGFBR1 ACVR2A ACVR2B	2.43e-05	20	57	3	GO:0004675
GeneOntologyMolecularFunction	alkylglycerophosphoethanolamine phosphodiesterase activity	GNA11 GNAQ	7.96e-05	5	57	2	GO:0047391
GeneOntologyMolecularFunction	inhibin binding	ACVR2A ACVR2B	7.96e-05	5	57	2	GO:0034711
GeneOntologyMolecularFunction	oleate transmembrane transporter activity	SLC27A1 SLC27A2	1.19e-04	6	57	2	GO:1901480
GeneOntologyMolecularFunction	very long-chain fatty acid-CoA ligase activity	SLC27A1 SLC27A2	3.55e-04	10	57	2	GO:0031957
GeneOntologyMolecularFunction	G protein-coupled receptor binding	GNA11 GNAI3 GNAL GNAQ GNAT2 ARAP1	3.89e-04	337	57	6	GO:0001664
GeneOntologyMolecularFunction	arachidonate-CoA ligase activity	SLC27A1 SLC27A2	4.33e-04	11	57	2	GO:0047676
GeneOntologyMolecularFunction	long-chain fatty acid-CoA ligase activity	SLC27A1 SLC27A2	8.21e-04	15	57	2	GO:0004467
GeneOntologyMolecularFunction	long-chain fatty acid transmembrane transporter activity	SLC27A1 SLC27A2	1.19e-03	18	57	2	GO:0005324
GeneOntologyMolecularFunction	U6 snRNA binding	PRPF4 LSM4	1.19e-03	18	57	2	GO:0017070
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	TGFBR1 ACVR2A ACVR2B LMTK3 STK35 MAP3K19	1.66e-03	446	57	6	GO:0004674
GeneOntologyMolecularFunction	transmembrane receptor protein kinase activity	TGFBR1 ACVR2A ACVR2B	1.85e-03	85	57	3	GO:0019199
GeneOntologyMolecularFunction	fatty acid transmembrane transporter activity	SLC27A1 SLC27A2	1.95e-03	23	57	2	GO:0015245
GeneOntologyMolecularFunction	transforming growth factor beta binding	TGFBR1 ACVR2B	2.49e-03	26	57	2	GO:0050431
GeneOntologyMolecularFunction	fatty acid ligase activity	SLC27A1 SLC27A2	2.49e-03	26	57	2	GO:0015645
GeneOntologyMolecularFunction	enzyme activator activity	SLC27A1 GNAQ OCRL LTF ACVR2B ARAP1 SYNGAP1	2.54e-03	656	57	7	GO:0008047
GeneOntologyMolecularFunction	CoA-ligase activity	SLC27A1 SLC27A2	2.68e-03	27	57	2	GO:0016405
GeneOntologyMolecularFunction	GTPase activity	GNA11 GNAI3 GNAL GNAQ GNAT2	2.85e-03	341	57	5	GO:0003924
GeneOntologyMolecularFunction	acid-thiol ligase activity	SLC27A1 SLC27A2	3.53e-03	31	57	2	GO:0016878
GeneOntologyBiologicalProcess	G protein-coupled dopamine receptor signaling pathway	GNA11 GNAI3 GNAL GNAQ	7.03e-06	44	58	4	GO:0007212
GeneOntologyBiologicalProcess	cellular response to dopamine	GNA11 GNAI3 GNAL GNAQ	3.15e-05	64	58	4	GO:1903351
GeneOntologyBiologicalProcess	response to dopamine	GNA11 GNAI3 GNAL GNAQ	3.56e-05	66	58	4	GO:1903350
GeneOntologyBiologicalProcess	cellular response to monoamine stimulus	GNA11 GNAI3 GNAL GNAQ	4.01e-05	68	58	4	GO:0071868
GeneOntologyBiologicalProcess	cellular response to catecholamine stimulus	GNA11 GNAI3 GNAL GNAQ	4.01e-05	68	58	4	GO:0071870
GeneOntologyBiologicalProcess	skeletal system development	PAPPA2 TGFBR1 DHRS3 ASH1L GNA11 GNAQ LTF ACVR2A ACVR2B	5.08e-05	615	58	9	GO:0001501
GeneOntologyBiologicalProcess	response to catecholamine	GNA11 GNAI3 GNAL GNAQ	5.30e-05	73	58	4	GO:0071869
GeneOntologyBiologicalProcess	response to monoamine	GNA11 GNAI3 GNAL GNAQ	5.59e-05	74	58	4	GO:0071867
GeneOntologyBiologicalProcess	melanocyte differentiation	TYRP1 GNA11 GNAQ	7.32e-05	29	58	3	GO:0030318
GeneOntologyBiologicalProcess	regulation of melanocyte differentiation	GNA11 GNAQ	1.62e-04	7	58	2	GO:0045634
GeneOntologyBiologicalProcess	pigment cell differentiation	TYRP1 GNA11 GNAQ	1.94e-04	40	58	3	GO:0050931
GeneOntologyBiologicalProcess	positive regulation of activin receptor signaling pathway	ACVR2A ACVR2B	2.15e-04	8	58	2	GO:0032927
GeneOntologyBiologicalProcess	phospholipase C-activating dopamine receptor signaling pathway	GNA11 GNAQ	2.76e-04	9	58	2	GO:0060158
GeneOntologyBiologicalProcess	regulation of pigment cell differentiation	GNA11 GNAQ	2.76e-04	9	58	2	GO:0050932
GeneOntologyBiologicalProcess	positive regulation of bone mineralization	LTF ACVR2A ACVR2B	3.55e-04	49	58	3	GO:0030501
GeneOntologyBiologicalProcess	pigmentation	TYRP1 GNA11 GNAQ GNAT2	4.23e-04	125	58	4	GO:0043473
GeneOntologyBiologicalProcess	phototransduction	GNA11 GNAQ GNAT2	4.47e-04	53	58	3	GO:0007602
GeneOntologyBiologicalProcess	ion channel modulating, G protein-coupled receptor signaling pathway	GNA11 GNAQ	5.04e-04	12	58	2	GO:0099105
GeneOntologyBiologicalProcess	detection of visible light	GNA11 GNAQ GNAT2	5.54e-04	57	58	3	GO:0009584
GeneOntologyBiologicalProcess	post-embryonic development	TGFBR1 ASH1L GNAQ ACVR2B	5.66e-04	135	58	4	GO:0009791
GeneOntologyBiologicalProcess	developmental pigmentation	TYRP1 GNA11 GNAQ	5.83e-04	58	58	3	GO:0048066
GeneOntologyBiologicalProcess	phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway	GNA11 GNAQ	5.94e-04	13	58	2	GO:0007207
GeneOntologyBiologicalProcess	endothelin receptor signaling pathway	GNA11 GNAQ	5.94e-04	13	58	2	GO:0086100
GeneOntologyBiologicalProcess	activin receptor signaling pathway	TGFBR1 ACVR2A ACVR2B	6.44e-04	60	58	3	GO:0032924
GeneOntologyBiologicalProcess	positive regulation of biomineral tissue development	LTF ACVR2A ACVR2B	6.44e-04	60	58	3	GO:0070169
GeneOntologyCellularComponent	heterotrimeric G-protein complex	GNA11 GNAI3 GNAL GNAQ GNAT2	3.84e-08	35	57	5	GO:0005834
GeneOntologyCellularComponent	GTPase complex	GNA11 GNAI3 GNAL GNAQ GNAT2	8.76e-08	41	57	5	GO:1905360
GeneOntologyCellularComponent	activin receptor complex	TGFBR1 ACVR2A ACVR2B	3.82e-07	6	57	3	GO:0048179
GeneOntologyCellularComponent	extrinsic component of cytoplasmic side of plasma membrane	GNA11 GNAI3 GNAL GNAQ GNAT2	4.33e-07	56	57	5	GO:0031234
GeneOntologyCellularComponent	plasma membrane protein complex	TGFBR1 KCNQ5 KCNQ2 GNA11 CACNA1I GNAI3 GNAL GNAQ ACVR2A GNAT2 ACVR2B	7.43e-06	785	57	11	GO:0098797
GeneOntologyCellularComponent	photoreceptor outer segment	DHRS3 GNA11 GNAQ OCRL GNAT2	1.30e-05	111	57	5	GO:0001750
GeneOntologyCellularComponent	extrinsic component of plasma membrane	GNA11 GNAI3 GNAL GNAQ GNAT2	3.58e-05	137	57	5	GO:0019897
GeneOntologyCellularComponent	photoreceptor cell cilium	DHRS3 GNA11 GNAQ OCRL GNAT2	3.84e-05	139	57	5	GO:0097733
GeneOntologyCellularComponent	9+0 non-motile cilium	DHRS3 GNA11 GNAQ OCRL GNAT2	6.06e-05	153	57	5	GO:0097731
GeneOntologyCellularComponent	cytoplasmic side of plasma membrane	GNA11 GNAI3 GNAL GNAQ GNAT2	1.48e-04	185	57	5	GO:0009898
GeneOntologyCellularComponent	non-motile cilium	DHRS3 GNA11 GNAQ OCRL GNAT2	1.94e-04	196	57	5	GO:0097730
GeneOntologyCellularComponent	cytoplasmic side of membrane	GNA11 GNAI3 GNAL GNAQ GNAT2	4.06e-04	230	57	5	GO:0098562
GeneOntologyCellularComponent	extrinsic component of membrane	GNA11 GNAI3 GNAL GNAQ GNAT2	4.06e-04	230	57	5	GO:0019898
GeneOntologyCellularComponent	membrane protein complex	TGFBR1 KCNQ5 KCNQ2 GNA11 CACNA1I GNAI3 GNAL GNAQ ACVR2A GNAT2 ACVR2B MICU2	6.04e-04	1498	57	12	GO:0098796
GeneOntologyCellularComponent	photoreceptor outer segment membrane	DHRS3 GNAT2	1.21e-03	19	57	2	GO:0042622
GeneOntologyCellularComponent	P-body	ZC3H12D LSM4 TRIM21	2.73e-03	102	57	3	GO:0000932
GeneOntologyCellularComponent	caveola	TGFBR1 SLC27A1 GNAQ	3.46e-03	111	57	3	GO:0005901
GeneOntologyCellularComponent	cation channel complex	KCNQ5 KCNQ2 CACNA1I MICU2	3.86e-03	235	57	4	GO:0034703
MousePheno	abnormal afterhyperpolarization	KCNQ5 KCNQ2 CACNA1I GNAQ	4.91e-07	17	55	4	MP:0003412
Domain	G-alpha	GNA11 GNAI3 GNAL GNAQ GNAT2	1.03e-09	16	58	5	PF00503
Domain	GproteinA_insert	GNA11 GNAI3 GNAL GNAQ GNAT2	1.03e-09	16	58	5	IPR011025
Domain	-	GNA11 GNAI3 GNAL GNAQ GNAT2	1.03e-09	16	58	5	1.10.400.10
Domain	G_alpha	GNA11 GNAI3 GNAL GNAQ GNAT2	1.03e-09	16	58	5	SM00275
Domain	Gprotein_alpha_su	GNA11 GNAI3 GNAL GNAQ GNAT2	1.46e-09	17	58	5	IPR001019
Domain	Activin_recp	TGFBR1 ACVR2A ACVR2B	3.36e-06	10	58	3	IPR000472
Domain	Activin_recp	TGFBR1 ACVR2A ACVR2B	3.36e-06	10	58	3	PF01064
Domain	TGFB_receptor	TGFBR1 ACVR2A ACVR2B	6.13e-06	12	58	3	IPR000333
Domain	K_chnl_volt-dep_KCNQ2	KCNQ5 KCNQ2	9.48e-06	2	58	2	IPR003947
Domain	Gprotein_alpha_Q	GNA11 GNAQ	5.66e-05	4	58	2	IPR000654
Domain	Znf_B-box_chordata	TRIM21 TRIM7	5.66e-05	4	58	2	IPR020457
Domain	K_chnl_volt-dep_KCNQ	KCNQ5 KCNQ2	9.42e-05	5	58	2	IPR003937
Domain	K_chnl_volt-dep_KCNQ_C	KCNQ5 KCNQ2	9.42e-05	5	58	2	IPR013821
Domain	KCNQ_channel	KCNQ5 KCNQ2	9.42e-05	5	58	2	PF03520
Domain	Gprotein_alpha_I	GNAI3 GNAT2	2.62e-04	8	58	2	IPR001408
Domain	AMP-bd_C	SLC27A1 SLC27A2	1.25e-03	17	58	2	IPR025110
Domain	AMP-binding_C	SLC27A1 SLC27A2	1.25e-03	17	58	2	PF13193
Domain	Rho_GTPase_activation_prot	OCRL ARAP1 SYNGAP1	2.59e-03	88	58	3	IPR008936
Domain	PROTEIN_KINASE_ATP	TGFBR1 ACVR2A ACVR2B LMTK3 STK35 MAP3K19	2.93e-03	459	58	6	PS00107
Domain	AMP-binding_CS	SLC27A1 SLC27A2	2.94e-03	26	58	2	IPR020845
Domain	AMP_BINDING	SLC27A1 SLC27A2	3.40e-03	28	58	2	PS00455
Domain	AMP-binding	SLC27A1 SLC27A2	3.90e-03	30	58	2	PF00501
Domain	AMP-dep_Synth/Lig	SLC27A1 SLC27A2	3.90e-03	30	58	2	IPR000873
Domain	PROTEIN_KINASE_DOM	TGFBR1 ACVR2A ACVR2B LMTK3 STK35 MAP3K19	4.16e-03	493	58	6	PS50011
Domain	VG_K_chnl	KCNQ5 KCNQ2	4.70e-03	33	58	2	IPR028325
Domain	ConA-like_dom	PAPPA2 CELSR3 TRIM21 TRIM7	4.76e-03	219	58	4	IPR013320
Domain	Ser/Thr_kinase_AS	TGFBR1 ACVR2A ACVR2B STK35 MAP3K19	4.96e-03	357	58	5	IPR008271
Domain	PROTEIN_KINASE_ST	TGFBR1 ACVR2A ACVR2B STK35 MAP3K19	5.26e-03	362	58	5	PS00108
Domain	Ion_trans_dom	KCNQ5 KCNQ2 CACNA1I	5.35e-03	114	58	3	IPR005821
Domain	Ion_trans	KCNQ5 KCNQ2 CACNA1I	5.35e-03	114	58	3	PF00520
Domain	RA	RASSF1 ARAP1	5.58e-03	36	58	2	PF00788
Domain	RA	RASSF1 ARAP1	5.89e-03	37	58	2	PS50200
Domain	Pkinase	TGFBR1 ACVR2A ACVR2B STK35 MAP3K19	6.50e-03	381	58	5	PF00069
Domain	RA_dom	RASSF1 ARAP1	6.85e-03	40	58	2	IPR000159
Domain	PRY	TRIM21 TRIM7	7.54e-03	42	58	2	PF13765
Domain	BTB-kelch_protein	KBTBD2 KLHL33	7.89e-03	43	58	2	IPR017096
Pathway	REACTOME_G_PROTEIN_MEDIATED_EVENTS	GNA11 GNAI3 GNAL GNAQ	8.92e-06	39	48	4	MM14496
Pathway	PID_ER_NONGENOMIC_PATHWAY	GNA11 GNAI3 GNAL GNAQ	9.88e-06	40	48	4	M41
Pathway	REACTOME_G_PROTEIN_MEDIATED_EVENTS	GNA11 GNAI3 GNAL GNAQ	3.30e-05	54	48	4	M26911
Pathway	PID_S1P_META_PATHWAY	GNA11 GNAI3 GNAQ	4.72e-05	21	48	3	M155
Pathway	PID_ENDOTHELIN_PATHWAY	GNA11 GNAI3 GNAL GNAQ	6.08e-05	63	48	4	M8
Pathway	PID_S1P_S1P2_PATHWAY	GNA11 GNAI3 GNAQ	7.13e-05	24	48	3	M268
Pathway	PID_ALK1_PATHWAY	TGFBR1 ACVR2A ACVR2B	9.12e-05	26	48	3	M185
Pathway	REACTOME_OPIOID_SIGNALLING	GNA11 GNAI3 GNAL GNAQ	9.72e-05	71	48	4	MM14491
Pathway	PID_S1P_S1P3_PATHWAY	GNA11 GNAI3 GNAQ	1.27e-04	29	48	3	M55
Pathway	KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY	GNA11 GNAQ	1.69e-04	6	48	2	M47548
Pathway	REACTOME_SIGNAL_AMPLIFICATION	GNA11 GNAI3 GNAQ	1.88e-04	33	48	3	MM15020
Pathway	REACTOME_SIGNAL_AMPLIFICATION	GNA11 GNAI3 GNAQ	1.88e-04	33	48	3	M9379
Pathway	REACTOME_OPIOID_SIGNALLING	GNA11 GNAI3 GNAL GNAQ	2.44e-04	90	48	4	M6467
Pathway	WP_G_PROTEIN_SIGNALING_PATHWAYS	GNA11 GNAI3 GNAL GNAQ	2.44e-04	90	48	4	MM15882
Pathway	WP_G_PROTEIN_SIGNALING	GNA11 GNAI3 GNAL GNAQ	2.54e-04	91	48	4	M39426
Pathway	REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION	GNA11 GNAQ	3.14e-04	8	48	2	MM15032
Pathway	REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION	GNA11 GNAQ	3.14e-04	8	48	2	M27356
Pathway	KEGG_MEDICUS_REFERENCE_NODAL_SIGNALING_PATHWAY	ACVR2A ACVR2B	3.14e-04	8	48	2	M47849
Pathway	KEGG_MEDICUS_REFERENCE_ACTIVIN_SIGNALING_PATHWAY	ACVR2A ACVR2B	3.14e-04	8	48	2	M47846
Pathway	KEGG_MEDICUS_REFERENCE_MYOSTATIN_SIGNALING_PATHWAY	TGFBR1 ACVR2B	3.14e-04	8	48	2	M47847
Pathway	REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION	GNA11 GNAQ	3.14e-04	8	48	2	MM15100
Pathway	WP_HIPPO_SIGNALING_REGULATION	GNA11 GNAI3 GNAL GNAQ	3.38e-04	98	48	4	M39830
Pathway	KEGG_MEDICUS_REFERENCE_LPA_GNAQ_11_RHOA_SIGNALING_PATHWAY	GNA11 GNAQ	4.03e-04	9	48	2	M47732
Pathway	PID_THROMBIN_PAR1_PATHWAY	GNA11 GNAI3 GNAQ	4.16e-04	43	48	3	M238
Pathway	REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION	GNA11 GNAQ	5.02e-04	10	48	2	M1825
Pathway	REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION	GNA11 GNAQ	6.12e-04	11	48	2	M27317
Pathway	REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION	GNA11 GNAQ	6.12e-04	11	48	2	MM15035
Pathway	KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY	GNA11 GNAQ	6.12e-04	11	48	2	M47637
Pathway	KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY	GNA11 GNAQ	7.33e-04	12	48	2	M47649
Pathway	REACTOME_REGULATION_OF_SIGNALING_BY_NODAL	ACVR2A ACVR2B	7.33e-04	12	48	2	M26952
Pathway	REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY	GNAI3 GNAL	1.01e-03	14	48	2	MM14669
Pathway	REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY	GNAI3 GNAL	1.01e-03	14	48	2	M750
Pathway	PID_THROMBIN_PAR4_PATHWAY	GNA11 GNAQ	1.16e-03	15	48	2	M138
Pathway	REACTOME_SIGNALING_BY_ACTIVIN	ACVR2A ACVR2B	1.16e-03	15	48	2	MM14593
Pathway	BIOCARTA_RACC_PATHWAY	KCNQ5 KCNQ2	1.16e-03	15	48	2	M22002
Pathway	PID_LYSOPHOSPHOLIPID_PATHWAY	GNA11 GNAI3 GNAQ	1.40e-03	65	48	3	M15
Pathway	REACTOME_SIGNALING_BY_ACTIVIN	ACVR2A ACVR2B	1.49e-03	17	48	2	M26965
Pathway	KEGG_LONG_TERM_DEPRESSION	GNA11 GNAI3 GNAQ	1.73e-03	70	48	3	M8232
Pathway	KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY	ACVR2A ACVR2B	2.07e-03	20	48	2	M47843
Pathway	REACTOME_SIGNALING_BY_TGFBR3	TGFBR1 ACVR2A	2.29e-03	21	48	2	MM17231
Pathway	KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY	GNA11 GNAQ	2.29e-03	21	48	2	M47638
Pathway	WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA	GNA11 GNAQ	2.51e-03	22	48	2	M39795
Pathway	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL	NCOA1 SLC27A2	2.74e-03	23	48	2	M1926
Pathway	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL	NCOA1 SLC27A2	2.74e-03	23	48	2	MM14741
Pathway	REACTOME_SIGNALING_BY_NODAL	ACVR2A ACVR2B	2.74e-03	23	48	2	M511
Pathway	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS	GNA11 GNAI3 GNAL GNAQ GNAT2	2.91e-03	289	48	5	MM15057
Pathway	REACTOME_G_PROTEIN_ACTIVATION	GNA11 GNAQ	2.99e-03	24	48	2	M13115
Pathway	REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR	GNA11 GNAQ	2.99e-03	24	48	2	M18308
Pathway	REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR	GNA11 GNAQ	2.99e-03	24	48	2	MM15088
Pathway	REACTOME_G_PROTEIN_ACTIVATION	GNA11 GNAQ	2.99e-03	24	48	2	MM14794
Pathway	WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY	GNA11 GNAI3 GNAQ	3.01e-03	85	48	3	M48315
Pathway	KEGG_CALCIUM_SIGNALING_PATHWAY	GNA11 CACNA1I GNAL GNAQ	3.10e-03	178	48	4	M2890
Pathway	KEGG_TGF_BETA_SIGNALING_PATHWAY	TGFBR1 ACVR2A ACVR2B	3.11e-03	86	48	3	M2642
Pathway	REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1	GNA11 GNAQ	3.24e-03	25	48	2	MM15056
Pathway	REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1	GNA11 GNAQ	3.24e-03	25	48	2	M811
Pathway	WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION	TGFBR1 RASSF1	3.50e-03	26	48	2	M48092
Pathway	KEGG_GAP_JUNCTION	GNA11 GNAI3 GNAQ	3.54e-03	90	48	3	M4013
Pubmed	G protein gene expression during mouse oocyte growth and maturation, and preimplantation embryo development.	GNA11 GNAI3 GNAL GNAQ GNAT2	1.13e-09	28	59	5	8858601
Pubmed	Selective inhibition of Cav3.3 T-type calcium channels by Galphaq/11-coupled muscarinic acetylcholine receptors.	GNA11 CACNA1I GNAQ	4.64e-09	3	59	3	17535809
Pubmed	Cloning and characterization of the human phosphoinositide-specific phospholipase C-beta 1 (PLC beta 1).	GNA11 GNAI3 GNAQ GNAT2	1.01e-08	15	59	4	11118617
Pubmed	Evolution of the mammalian G protein alpha subunit multigene family.	GNA11 GNAI3 GNAL GNAQ GNAT2	2.13e-08	49	59	5	1302014
Pubmed	Local versus systemic control of bone and skeletal muscle mass by components of the transforming growth factor-β signaling pathway.	TGFBR1 ACVR2A ACVR2B	4.63e-08	5	59	3	34385332
Pubmed	D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum.	GNA11 GNAL GNAQ	9.24e-08	6	59	3	17194762
Pubmed	Activation of signalling by the activin receptor complex.	TGFBR1 ACVR2A ACVR2B	9.24e-08	6	59	3	8622651
Pubmed	METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis.	SCO2 CELSR3 SND1 GNAI3 GNAL GNAT2 NSUN2	1.32e-07	231	59	7	36597993
Pubmed	Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2.	TGFBR1 ACVR2A ACVR2B	1.62e-07	7	59	3	9748228
Pubmed	Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors.	TGFBR1 ACVR2A ACVR2B	2.58e-07	8	59	3	8242742
Pubmed	Phospholipase C-beta 1 is a GTPase-activating protein for Gq/11, its physiologic regulator.	GNA11 GNAQ GNAT2	3.87e-07	9	59	3	1322796
Pubmed	Human retroviral gag- and gag-pol-like proteins interact with the transforming growth factor-beta receptor activin receptor-like kinase 1.	TGFBR1 ACVR2A ACVR2B	5.52e-07	10	59	3	15611116
Pubmed	The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families.	GNA11 GNAI3 GNAQ	5.52e-07	10	59	3	8552586
Pubmed	Knockout mouse models reveal the contributions of G protein subunits to complement C5a receptor-mediated chemotaxis.	GNA11 GNAI3 GNAQ	7.58e-07	11	59	3	32332099
Pubmed	Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily.	TGFBR1 ACVR2A ACVR2B	7.58e-07	11	59	3	9872992
Pubmed	Diversity of the G-protein family: sequences from five additional alpha subunits in the mouse.	GNA11 GNAI3 GNAL	1.01e-06	12	59	3	2508088
Pubmed	Epithelial and ectomesenchymal role of the type I TGF-beta receptor ALK5 during facial morphogenesis and palatal fusion.	TGFBR1 ACVR2A ACVR2B	1.01e-06	12	59	3	16806156
Pubmed	Signaling through the TGF beta-activin receptors ALK4/5/7 regulates testis formation and male germ cell development.	TGFBR1 ACVR2A ACVR2B	1.01e-06	12	59	3	23342175
Pubmed	Mechanism of GTP hydrolysis by G-protein alpha subunits.	GNA11 GNAL GNAQ	2.08e-06	15	59	3	7937899
Pubmed	GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis.	GNA11 GNAQ	2.83e-06	2	59	2	27498141
Pubmed	The Role of Mutation Rates of GNAQ or GNA11 in Cases of Uveal Melanoma in Japan.	GNA11 GNAQ	2.83e-06	2	59	2	28248732
Pubmed	Uveal Melanoma: GNAQ and GNA11 Mutations in a Greek Population.	GNA11 GNAQ	2.83e-06	2	59	2	28982892
Pubmed	Mutations in GNA11 in uveal melanoma.	GNA11 GNAQ	2.83e-06	2	59	2	21083380
Pubmed	Activation of Gq/11 in the mouse corpus luteum is required for parturition.	GNA11 GNAQ	2.83e-06	2	59	2	25495873
Pubmed	GNAQ and GNA11 mutations in uveal melanoma.	GNA11 GNAQ	2.83e-06	2	59	2	25304237
Pubmed	mRNAs for activin receptors II and IIB are expressed in mouse oocytes and in the epiblast of pregastrula and gastrula stage mouse embryos.	ACVR2A ACVR2B	2.83e-06	2	59	2	7748787
Pubmed	Epidermal loss of Gαq confers a migratory and differentiation defect in keratinocytes.	GNA11 GNAQ	2.83e-06	2	59	2	28301547
Pubmed	Forebrain-specific inactivation of Gq/G11 family G proteins results in age-dependent epilepsy and impaired endocannabinoid formation.	GNA11 GNAQ	2.83e-06	2	59	2	16847339
Pubmed	Uveal melanoma driver mutations in GNAQ/11 yield numerous changes in melanocyte biology.	GNA11 GNAQ	2.83e-06	2	59	2	29570931
Pubmed	Muscarinic inhibition of calcium current and M current in Galpha q-deficient mice.	GNA11 GNAQ	2.83e-06	2	59	2	10818132
Pubmed	Overexpression of human fatty acid transport protein 2/very long chain acyl-CoA synthetase 1 (FATP2/Acsvl1) reveals distinct patterns of trafficking of exogenous fatty acids.	SLC27A1 SLC27A2	2.83e-06	2	59	2	24113382
Pubmed	Endothelial Gαq/11 is required for VEGF-induced vascular permeability and angiogenesis.	GNA11 GNAQ	2.83e-06	2	59	2	26272756
Pubmed	NK2 receptor-mediated detrusor muscle contraction involves Gq/11-dependent activation of voltage-dependent Ca2+ channels and the RhoA-Rho kinase pathway.	GNA11 GNAQ	2.83e-06	2	59	2	31461351
Pubmed	Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma.	GNA11 GNAQ	2.83e-06	2	59	2	23634288
Pubmed	Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism.	GNA11 GNAQ	2.83e-06	2	59	2	26368812
Pubmed	Postsynaptic mechanisms underlying responsiveness of amygdaloid neurons to cholecystokinin are mediated by a transient receptor potential-like current.	GNA11 GNAQ	2.83e-06	2	59	2	17482476
Pubmed	The ferroportin-ceruloplasmin system and the mammalian iron homeostasis machine: regulatory pathways and the role of lactoferrin.	LTF SLC40A1	2.83e-06	2	59	2	29453656
Pubmed	KCNQ2 and KCNQ5 form heteromeric channels independent of KCNQ3.	KCNQ5 KCNQ2	2.83e-06	2	59	2	35320039
Pubmed	Molecular genetic testing of uveal melanoma from routinely processed and stained cytology specimens.	GNA11 GNAQ	2.83e-06	2	59	2	21945171
Pubmed	Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations.	GNA11 GNAQ	2.83e-06	2	59	2	24141786
Pubmed	Interaction of the G-protein G11alpha with receptors and phosphoinositidase C: the contribution of G-protein palmitoylation and membrane association.	GNA11 GNAQ	2.83e-06	2	59	2	9175863
Pubmed	The ethnic profile of patients with birthmarks reveals interaction of germline and postzygotic genetics.	GNA11 GNAQ	2.83e-06	2	59	2	28083870
Pubmed	Stretch regulates alveologenesis and homeostasis via mesenchymal Gαq/11-mediated TGFβ2 activation.	GNA11 GNAQ	2.83e-06	2	59	2	37102682
Pubmed	Gq/11-Dependent Changes in the Murine Ovarian Transcriptome at the End of Gestation.	GNA11 GNAQ	2.83e-06	2	59	2	26843449
Pubmed	Direct targeting of Gαq and Gα11 oncoproteins in cancer cells.	GNA11 GNAQ	2.83e-06	2	59	2	30890659
Pubmed	Ca2+ signalling in K562 human erythroleukaemia cells: effect of dimethyl sulphoxide and role of G-proteins in thrombin- and thromboxane A2-activated pathways.	GNA11 GNAQ	2.83e-06	2	59	2	7492305
Pubmed	Reduced trabecular bone mass and strength in mice overexpressing Gα11 protein in cells of the osteoblast lineage.	GNA11 GNAQ	2.83e-06	2	59	2	24308950
Pubmed	Gαq and Gα11 contribute to the maintenance of cellular electrophysiology and Ca2+ handling in ventricular cardiomyocytes.	GNA11 GNAQ	2.83e-06	2	59	2	22562663
Pubmed	Functional specificity of G alpha q and G alpha 11 in the cholinergic and glutamatergic modulation of potassium currents and excitability in hippocampal neurons.	GNA11 GNAQ	2.83e-06	2	59	2	11826096
Pubmed	Blue nevi and variants: an update.	GNA11 GNAQ	2.83e-06	2	59	2	21366456
Pubmed	Formation and activation by phosphorylation of activin receptor complexes.	ACVR2A ACVR2B	2.83e-06	2	59	2	8721982
Pubmed	In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutations.	GNA11 GNAQ	2.83e-06	2	59	2	35580369
Pubmed	Gonadotropin and gonadal steroid release in response to a gonadotropin-releasing hormone agonist in Gqalpha and G11alpha knockout mice.	GNA11 GNAQ	2.83e-06	2	59	2	9607776
Pubmed	Reverse Phenotyping in Patients with Skin Capillary Malformations and Mosaic GNAQ or GNA11 Mutations Defines a Clinical Spectrum with Genotype-Phenotype Correlation.	GNA11 GNAQ	2.83e-06	2	59	2	31726051
Pubmed	Papillary Hemangioma Harbors Somatic GNA11 and GNAQ Mutations.	GNA11 GNAQ	2.83e-06	2	59	2	37750536
Pubmed	G(alpha)q-deficient mice lack metabotropic glutamate receptor-dependent long-term depression but show normal long-term potentiation in the hippocampal CA1 region.	GNA11 GNAQ	2.83e-06	2	59	2	11438569
Pubmed	GNAQ/GNA11 Mosaicism Is Associated with Abnormal Serum Calcium Indices and Microvascular Neurocalcification.	GNA11 GNAQ	2.83e-06	2	59	2	37802294
Pubmed	Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis.	GNA11 GNAQ	2.83e-06	2	59	2	26778290
Pubmed	Distinct profiles of functional discrimination among G proteins determine the actions of G protein-coupled receptors.	GNA11 GNAQ	2.83e-06	2	59	2	26628681
Pubmed	Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass.	ACVR2A ACVR2B	2.83e-06	2	59	2	28659341
Pubmed	Skeletal Muscle-Specific Activation of Gq Signaling Maintains Glucose Homeostasis.	GNA11 GNAQ	2.83e-06	2	59	2	30936140
Pubmed	The time-course of agonist-induced solubilization of trimeric G(q)alpha/G(11)alpha proteins resolved by two-dimensional electrophoresis.	GNA11 GNAQ	2.83e-06	2	59	2	17552882
Pubmed	Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11.	GNA11 GNAQ	2.83e-06	2	59	2	23778528
Pubmed	High throughput mass spectrometry-based mutation profiling of primary uveal melanoma.	GNA11 GNAQ	2.83e-06	2	59	2	22977135
Pubmed	An experimental strategy to probe Gq contribution to signal transduction in living cells.	GNA11 GNAQ	2.83e-06	2	59	2	33639168
Pubmed	GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma.	GNA11 GNAQ	2.83e-06	2	59	2	32064597
Pubmed	Mutational analysis of GNAQ and GNA11 to aid therapy management of a choroidal melanoma metastatic to the contralateral orbit.	GNA11 GNAQ	2.83e-06	2	59	2	23572068
Pubmed	Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations.	GNA11 GNAQ	2.83e-06	2	59	2	31173078
Pubmed	Low mutational burden of eight genes involved in the MAPK/ERK, PI3K/AKT, and GNAQ/11 pathways in female genital tract primary melanomas.	GNA11 GNAQ	2.83e-06	2	59	2	25695059
Pubmed	Frequent and Yet Unreported GNAQ and GNA11 Mutations are Found in Uveal Melanomas.	GNA11 GNAQ	2.83e-06	2	59	2	29209985
Pubmed	Group I metabotropic glutamate receptor signaling via Galpha q/Galpha 11 secures the induction of long-term potentiation in the hippocampal area CA1.	GNA11 GNAQ	2.83e-06	2	59	2	12351712
Pubmed	Cardiac remodeling in Gαq and Gα11 knockout mice.	GNA11 GNAQ	2.83e-06	2	59	2	26476043
Pubmed	Expression of activin receptor II and IIB mRNA isoforms in mouse reproductive organs and oocytes.	ACVR2A ACVR2B	2.83e-06	2	59	2	8049070
Pubmed	Structure of the mouse activin receptor type II gene.	ACVR2A ACVR2B	2.83e-06	2	59	2	1318045
Pubmed	Characterization of type II activin receptors. Binding, processing, and phosphorylation.	ACVR2A ACVR2B	2.83e-06	2	59	2	8395525
Pubmed	Early-onset hypertension associated with extensive cutaneous capillary malformations harboring postzygotic variants in GNAQ and GNA11.	GNA11 GNAQ	2.83e-06	2	59	2	36440997
Pubmed	Loss of Gq/11 family G proteins in the nervous system causes pituitary somatotroph hypoplasia and dwarfism in mice.	GNA11 GNAQ	2.83e-06	2	59	2	15713647
Pubmed	Distinct roles of Galpha(q) and Galpha11 for Purkinje cell signaling and motor behavior.	GNA11 GNAQ	2.83e-06	2	59	2	15175381
Pubmed	GNAQ and GNA11 mutations in melanocytomas of the central nervous system.	GNA11 GNAQ	2.83e-06	2	59	2	22307269
Pubmed	Oncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese.	GNA11 GNAQ	2.83e-06	2	59	2	25280020
Pubmed	Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma.	GNA11 GNAQ	8.48e-06	3	59	2	28700778
Pubmed	Dissecting Gq/11-Mediated Plasma Membrane Translocation of Sphingosine Kinase-1.	GNA11 GNAQ	8.48e-06	3	59	2	33003441
Pubmed	P2Y₂ and Gq/G₁₁ control blood pressure by mediating endothelial mechanotransduction.	GNA11 GNAQ	8.48e-06	3	59	2	26168216
Pubmed	The prostacyclin receptor is isoprenylated. Isoprenylation is required for efficient receptor-effector coupling.	GNA11 GNAQ	8.48e-06	3	59	2	10446129
Pubmed	Specificity of G alpha q and G alpha 11 gene expression in platelets and erythrocytes. Expressions of cellular differentiation and species differences.	GNA11 GNAQ	8.48e-06	3	59	2	8836152
Pubmed	Gqα/G11α deficiency in dorsomedial hypothalamus leads to obesity resulting from decreased energy expenditure and impaired sympathetic nerve activity.	GNA11 GNAQ	8.48e-06	3	59	2	33166186
Pubmed	Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes.	GNA11 GNAQ	8.48e-06	3	59	2	11689889
Pubmed	Expression of activin subunits and receptors in the developing human ovary: activin A promotes germ cell survival and proliferation before primordial follicle formation.	ACVR2A ACVR2B	8.48e-06	3	59	2	14738881
Pubmed	Diabetes-related defects in sarcoplasmic Ca2+ release are prevented by inactivation of G(alpha)11 and G(alpha)q in murine cardiomyocytes.	GNA11 GNAQ	8.48e-06	3	59	2	20372981
Pubmed	Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension.	GNA11 GNAQ	8.48e-06	3	59	2	25595485
Pubmed	The orphan receptor GPR139 signals via Gq/11 to oppose opioid effects.	GNA11 GNAQ	8.48e-06	3	59	2	32576659
Pubmed	Thyrocyte-specific Gq/G11 deficiency impairs thyroid function and prevents goiter development.	GNA11 GNAQ	8.48e-06	3	59	2	17694176
Pubmed	Localization of KCNQ5 in the normal and epileptic human temporal neocortex and hippocampal formation.	KCNQ5 KCNQ2	8.48e-06	3	59	2	12890507
Pubmed	Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi.	GNA11 GNAQ	8.48e-06	3	59	2	23599145
Pubmed	Heterotrimeric G proteins of the Gq/11 family are crucial for the induction of maternal behavior in mice.	GNA11 GNAQ	8.48e-06	3	59	2	15340067
Pubmed	Galphao2 regulates vesicular glutamate transporter activity by changing its chloride dependence.	GNA11 GNAQ	8.48e-06	3	59	2	15872115
Pubmed	GNA11 and N-RAS mutations: alternatives for MAPK pathway activating GNAQ mutations in primary melanocytic tumours of the central nervous system.	GNA11 GNAQ	8.48e-06	3	59	2	22758774
Pubmed	Regulation of the epithelial Na+ channel by the RH domain of G protein-coupled receptor kinase, GRK2, and Galphaq/11.	GNA11 GNAQ	8.48e-06	3	59	2	21464134
Pubmed	G protein diversity: a distinct class of alpha subunits is present in vertebrates and invertebrates.	GNA11 GNAQ	8.48e-06	3	59	2	2123549
Pubmed	Regulation of muscle growth by multiple ligands signaling through activin type II receptors.	ACVR2A ACVR2B	8.48e-06	3	59	2	16330774
Interaction	GNG4 interactions	DHRS3 GNA11 GNAI3 GNAQ	8.00e-07	25	59	4	int:GNG4
Interaction	RGS16 interactions	GNAI3 GNAQ ST14	1.57e-05	17	59	3	int:RGS16
Interaction	METTL14 interactions	SCO2 CELSR3 SND1 LSM4 GNAI3 GNAL LTF GNAT2 NSUN2	3.28e-05	558	59	9	int:METTL14
Interaction	GNAO1 interactions	GNA11 GNAI3 GNAQ GNAT2 SYNGAP1	4.21e-05	132	59	5	int:GNAO1
Interaction	GNG3 interactions	GNA11 GNAQ GNAT2	4.62e-05	24	59	3	int:GNG3
Interaction	ZDHHC23 interactions	NCOA1 GNA11 GNAQ GLIS1	6.54e-05	74	59	4	int:ZDHHC23
GeneFamily	Type 2 receptor serine/threonine kinases	ACVR2A ACVR2B	5.00e-05	5	41	2	346
GeneFamily	Acyl-CoA synthetase family	SLC27A1 SLC27A2	1.58e-03	26	41	2	40
GeneFamily	Potassium voltage-gated channels	KCNQ5 KCNQ2	3.71e-03	40	41	2	274
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	PAPPA2 CSMD3	7.40e-03	57	41	2	1179
Coexpression	LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_NEGATIVE	WDFY4 SLC40A1 SLC27A2	1.02e-05	19	59	3	M41038
Coexpression	GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_DN	PAPPA2 NEURL3 ASH1L GNA11 ACVR2A	2.31e-05	151	59	5	M369
ToppCell	NS-critical-d_0-4-Epithelial-FOXN4+\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LMF1 BOK BEND3 LIPT2 GNA11 OCRL	1.09e-07	172	59	6	a00bb44d33658cb3a98accd6b60f3ce964c425b4
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NEURL3 BEND3 LTF PLEKHO1 PRODH	3.55e-06	175	59	5	dbd9dac129fb6ae5f55e7b96d04b37585458dc4a
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TGFBR1 CD5L DHRS3 WDFY4 ARAP1	5.72e-06	193	59	5	697518bab1338dc441b2d93b410d957e692f20e6
ToppCell	proximal-Epithelial-Differentiating_Basal-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NEURL3 DHRS3 LMTK3 SLC27A2 TRIM7	6.64e-06	199	59	5	c607346f60e5997e757e5a31cab412ab3734377b
ToppCell	proximal-3-Epithelial-Differentiating_Basal\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NEURL3 DHRS3 LMTK3 SLC27A2 TRIM7	6.64e-06	199	59	5	12e07084fc2d5d4c418df564ccc0e132b056e549
ToppCell	proximal-Epithelial-Differentiating_Basal\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NEURL3 DHRS3 LMTK3 SLC27A2 TRIM7	6.64e-06	199	59	5	96a89a2578fad9a99c52d2cf9e26e06516a96568
ToppCell	PND07-Immune-Immune_Myeloid-DC-cDC2\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NEURL3 KCNQ2 WDFY4 PLEKHO1	4.56e-05	149	59	4	32e0be7da42d26956683b21a1e7ae6915e4c16fb
ToppCell	facs-Marrow-B-cells-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNQ2 LTF LY75 SLC40A1	5.59e-05	157	59	4	0673c7161c25feceee8f1e5fd237171576c42c6b
ToppCell	facs-Marrow-B-cells-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNQ2 LTF LY75 SLC40A1	5.59e-05	157	59	4	d307d0b48af35e0e1af41ecd3ebf91be8fd29dc0
ToppCell	droplet-Liver-Hepatocytes-18m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD5L TRIM21 SLC40A1 ARAP1	5.73e-05	158	59	4	d3446fc98eff09c3626b47a2c90d07cd985378b5
ToppCell	droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD5L TRIM21 SLC40A1 ARAP1	5.73e-05	158	59	4	df614450e10629dc9115d7365397663e82f9e48f
ToppCell	droplet-Heart-nan-24m-Hematologic-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZC3H12D LY75 WDFY4 TRIM7	6.17e-05	161	59	4	7e60001637ef0f6fc67ef8a36ab80ebb25b0b0ab
ToppCell	facs\|World / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DHRS3 GNA11 GNAQ TRIM7	7.79e-05	171	59	4	5bcb96ed7fc15548f2dc9cf47482f890640cb39c
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-Macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD5L PRXL2B NCOA1 SLC40A1	7.79e-05	171	59	4	a474aaed3ca4cacb0ab565c35f25d92a10f531b7
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DHRS3 BEND3 ACVR2A PRODH	7.79e-05	171	59	4	d1e87478d8c0329e662849823f5c7604f20e1b1a
ToppCell	facs\|World / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DHRS3 GNA11 GNAQ TRIM7	7.79e-05	171	59	4	bb71e816dde44fda6af0ad98d979be9f8740fda6
ToppCell	droplet-Lung-LUNG-30m-Lymphocytic-Zbtb32+_B\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1I KLHL33 WDFY4 TRIM7	8.33e-05	174	59	4	28ec25767bbd4fd898738f9f4d2b585dc91b5adf
ToppCell	normal_Lung-T/NK_cells-Exhausted_Tfh\|T/NK_cells / Location, Cell class and cell subclass	KCNQ5 GNA11 PLEKHO1 SLC27A2	8.33e-05	174	59	4	e324320b52c904496e26fcecfa179b3431729ec0
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CD5L OCRL ACVR2A TRIM7	9.10e-05	178	59	4	9d575902d3dbe33437c9d4200df093a741269803
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNQ5 ZC3H12D CACNA1I TRIM7	9.10e-05	178	59	4	ba5a477257877f4a15a91c1762ffcc6f2e9f7357
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNQ5 ZC3H12D CACNA1I TRIM7	9.10e-05	178	59	4	5634c1fbc817758092af4feafff94d107412d89b
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_3\|368C / Donor, Lineage, Cell class and subclass (all cells)	CD5L OCRL WDFY4 TRIM7	9.10e-05	178	59	4	536a601abcc60867949ea06e9aafb6c7b799b56b
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CELSR3 PRXL2B KCNQ2 STK35	9.50e-05	180	59	4	c72f15763ba707189e29c85db533557f01c7fdb1
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic-B_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEURL3 ZC3H12D WDFY4 TRIM7	1.01e-04	183	59	4	20f7b6ec2462032eda957a893ca76d5a5a01333d
ToppCell	facs-Lung-3m-Hematologic-lymphocytic-B_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZC3H12D CACNA1I WDFY4 TRIM7	1.10e-04	187	59	4	57f9c9162694c184a8fd6634ee0fad511ca71c9e
ToppCell	facs-Lung-3m-Hematologic-lymphocytic-B_cell-B_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZC3H12D CACNA1I WDFY4 TRIM7	1.10e-04	187	59	4	6ce6d3678026101c4397320430433c9f05740883
ToppCell	distal-Hematologic-IGSF21+_Dendritic-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ZC3H12D CACNA1I PLEKHO1 SLC40A1	1.24e-04	193	59	4	48ce11778252ae2ef902b30816061b59a3c81695
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TGFBR1 CD5L DHRS3 PLEKHO1	1.24e-04	193	59	4	b52d5661edff83ac4c5fe2bf89d6672016bb827b
ToppCell	Control-Myeloid-MoAM4\|Myeloid / Condition, Lineage and Cell class	TGFBR1 PLEKHO1 SLC40A1 ST14	1.27e-04	194	59	4	7ab808dd1876b0eec2831caa16d04fd859b1dc50
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GNAQ WDFY4 PLEKHO1 ST14	1.27e-04	194	59	4	b16ed97eb6b7b7a220e943474c0d85c141b6e3a5
ToppCell	distal-1-Hematologic-IGSF21+_Dendritic\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ZC3H12D CACNA1I PLEKHO1 SLC40A1	1.27e-04	194	59	4	f30c866e5f41ee79bdc6b6e08af962d62b199835
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	GNAQ WDFY4 PLEKHO1 ST14	1.27e-04	194	59	4	2210f0755882d8f04edb4c109fb17c3f9149f6f7
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DHRS3 ZC3H12D CACNA1I GNAQ	1.27e-04	194	59	4	a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2
ToppCell	Control-Myeloid-MoAM4\|Control / Condition, Lineage and Cell class	TGFBR1 PLEKHO1 SLC40A1 ST14	1.29e-04	195	59	4	211a736acbe875bd3c1942c62aaacc9b170ece6d
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ZC3H12D LSM4 WDFY4 PLEKHO1	1.32e-04	196	59	4	b71d711be5609115b00a57700885aca608920896
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	BOK DHRS3 RASSF1 GNAL	1.32e-04	196	59	4	77da6b1bcab45d376eb0368f540e0ed24ce98b42
ToppCell	COVID-19_Severe-Lymphoid_T/NK-NK\|COVID-19_Severe / Disease group, lineage and cell class	BOK DHRS3 RASSF1 GNAL	1.32e-04	196	59	4	cc1daf12de5765ba4f7002396352404b41df2012
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	BOK DHRS3 RASSF1 GNAL	1.32e-04	196	59	4	d3bd8fab010e76024d7e06aba0ea5df3394f411f
ToppCell	PBMC-Control-cDC_3\|Control / Compartment, Disease Groups and Clusters	DHRS3 LY75 WDFY4 ST14	1.32e-04	196	59	4	09d197b321ff9f13c0672ea059c850845b0dbbd5
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BOK DHRS3 RASSF1 GNAL	1.34e-04	197	59	4	9993fdea353abeafc009ac87439ad25cedf8f1f6
ToppCell	hematopoetic_progenitors-CD34+_MEP_1\|hematopoetic_progenitors / Lineage and Cell class	DHRS3 GNAQ SLC40A1 SLC27A2	1.34e-04	197	59	4	6172a1b98ff840d9174b1ab20ba0c202a7ef87af
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BOK DHRS3 RASSF1 GNAL	1.34e-04	197	59	4	a8b41fffa4e86f2766423392951ff320e821a19a
ToppCell	COVID-19_Severe-CD4+_Tcm\|COVID-19_Severe / Disease condition and Cell class	ZC3H12D GNAQ ACVR2A SLC40A1	1.34e-04	197	59	4	f69083480ccf6f1854e5031d1a3e181bdcc8aea0
ToppCell	severe_COVID-19-NK\|severe_COVID-19 / disease group, cell group and cell class (v2)	BOK DHRS3 RASSF1 GNAL	1.37e-04	198	59	4	7f51e37516f717e424190e6584f1c74d357e2da4
ToppCell	proximal-3-Epithelial-Goblet\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LMTK3 ST14 SLC27A2 TRIM7	1.37e-04	198	59	4	3477202c4f702d8f75231b13d4b5216f56d981d7
ToppCell	severe_COVID-19-NK\|World / disease group, cell group and cell class (v2)	BOK DHRS3 RASSF1 GNAL	1.37e-04	198	59	4	36b1370ef68c4bbe0268933a6ef5e6022d992bdf
ToppCell	proximal-Epithelial-Goblet-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LMTK3 ST14 SLC27A2 TRIM7	1.37e-04	198	59	4	da7b40eb00bb5e454e1cfcd1219dc0d84712592a
ToppCell	proximal-Epithelial-Goblet\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LMTK3 ST14 SLC27A2 TRIM7	1.37e-04	198	59	4	e7e1c430486a81280abc4a7e7f5bc3713dd20737
ToppCell	wk_15-18-Hematologic-Myeloid-APOE+_Mac1\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CD5L KATNB1 TRIM21 SLC40A1	1.37e-04	198	59	4	88182ad964db88cf85b3e3a64929d07d59a923c2
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CD5L WDFY4 PLEKHO1 SLC40A1	1.40e-04	199	59	4	ca0f6526ba0dcf8789dd3b583291519626427f2f
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_basal-Dividing_Basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NEURL3 LMTK3 PRODH SLC27A2	1.40e-04	199	59	4	fe22833e69928a1478df265e1c356c463611dedd
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK\|COVID-19_Severe / Disease, condition lineage and cell class	BOK DHRS3 RASSF1 GNAL	1.42e-04	200	59	4	2580b7b83ba707718fe23ffca986e7a55ea85bce
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-mo-Mac\|Myeloid_cells / Location, Cell class and cell subclass	TGFBR1 DHRS3 SLC40A1 ST14	1.42e-04	200	59	4	195862a319794e57f0506757ae45ab70200bc5b4
ToppCell	Tracheal-10x3prime_v2-Epithelial-Epi_airway_basal-Suprabasal\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	NEURL3 LTF LMTK3 TRIM7	1.42e-04	200	59	4	d536180a308abc5703d5c8bb33dfe57dc4cc6577
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DHRS3 WDFY4 ST14 ARAP1	1.42e-04	200	59	4	80e0483d5ab0c6213aae0ec62619f57e6ec0e4c2
ToppCell	PBMC-Severe-cDC_1\|Severe / Compartment, Disease Groups and Clusters	SCO2 BEND3 WDFY4	1.70e-04	81	59	3	6d1e524f000b71c935359afc801a1d31f218fec8
ToppCell	Frontal_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CD5L NEURL3 WDFY4	2.56e-04	93	59	3	d102a0a015a2866e3fe549ac8796b9a0d5923d7e
ToppCell	Frontal_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CD5L NEURL3 WDFY4	2.56e-04	93	59	3	0967a93dcc72d2d8f12d56de186ec1af55c36001
ToppCell	Frontal_cortex-Hematopoietic-MACROPHAGE\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CD5L NEURL3 WDFY4	2.56e-04	93	59	3	1a112bd4e5e63826efad0338ce99d7a7ad9c72b9
ToppCell	Frontal_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CD5L NEURL3 WDFY4	2.56e-04	93	59	3	9c566fc2a8c7630bea28e8e46df55454aa409bc1
ToppCell	Frontal_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CD5L NEURL3 WDFY4	2.56e-04	93	59	3	613c827a643a7b6d70ef932cfa1762e90bc5a338
Drug	carisbamate	KCNQ5 KCNQ2 LTF	9.04e-06	16	59	3	CID006918474
Drug	magnesium fluoride	GNAI3 GNAL GNAQ GNAT2	1.08e-05	53	59	4	CID000024546
Drug	Gly-His-Lys acetate salt; Up 200; 1uM; PC3; HT_HG-U133A	PRPF4 RASSF1 KATNB1 LSM4 OCRL SLC27A2	1.16e-05	196	59	6	6570_UP
Drug	hp 5B	GNAL GNAQ LTF	1.56e-05	19	59	3	CID000123651
Drug	C24:0	AGL SLC27A1 ST14 SLC27A2	1.90e-05	61	59	4	CID000011197
Drug	TAAD	TGFBR1 ACVR2A ACVR2B	2.13e-05	21	59	3	CID000133445
Drug	ap1-6	TGFBR1 ACVR2A ACVR2B	2.82e-05	23	59	3	CID003030073
Disease	Phakomatosis cesioflammea	GNA11 GNAQ	3.93e-06	2	59	2	C3838883
Disease	Congenital hemangioma	GNA11 GNAQ	3.93e-06	2	59	2	C0235753
Disease	Port-wine stain with oculocutaneous melanosis	GNA11 GNAQ	3.93e-06	2	59	2	C1274879
Disease	Malignant melanoma of iris	GNA11 GNAQ	3.92e-05	5	59	2	C0346373
Disease	Malignant melanoma of choroid	GNA11 GNAQ	3.92e-05	5	59	2	C0346388
Disease	Uveal melanoma	GNA11 GNAQ	1.09e-04	8	59	2	C0220633
Disease	McCune Albright syndrome (implicated_via_orthology)	GNAI3 GNAT2	1.09e-04	8	59	2	DOID:1858 (implicated_via_orthology)
Disease	Marfan syndrome (implicated_via_orthology)	ACVR2A ACVR2B	1.75e-04	10	59	2	DOID:14323 (implicated_via_orthology)
Disease	long QT syndrome (implicated_via_orthology)	KCNQ5 KCNQ2	1.75e-04	10	59	2	DOID:2843 (implicated_via_orthology)
Disease	Autistic Disorder	SND1 CSMD3 WDFY4 SLC40A1 SYNGAP1	1.77e-04	261	59	5	C0004352
Disease	juvenile polyposis syndrome (implicated_via_orthology)	ACVR2A ACVR2B	3.02e-04	13	59	2	DOID:0050787 (implicated_via_orthology)
Disease	developmental and epileptic encephalopathy (implicated_via_orthology)	KCNQ5 KCNQ2	3.02e-04	13	59	2	DOID:0112202 (implicated_via_orthology)
Disease	schizophrenia (implicated_via_orthology)	CSMD3 PRODH SYNGAP1	3.47e-04	68	59	3	DOID:5419 (implicated_via_orthology)
Disease	renal cell carcinoma (is_implicated_in)	RASSF1 LTF XRCC1	3.62e-04	69	59	3	DOID:4450 (is_implicated_in)
Disease	Myopia	SCO2 KCNQ5	4.06e-04	15	59	2	C0027092
Disease	peak expiratory flow	PAPPA2 BOK KCNQ5 ZC3H12D NCOA1 KCNQ2	4.74e-04	498	59	6	EFO_0009718
Disease	urinary bladder cancer (is_implicated_in)	TGFBR1 RASSF1 XRCC1	4.81e-04	76	59	3	DOID:11054 (is_implicated_in)
Disease	Neurodevelopmental Disorders	ASH1L KCNQ2 SYNGAP1	8.67e-04	93	59	3	C1535926
Disease	transitional cell carcinoma (is_implicated_in)	RASSF1 XRCC1	8.85e-04	22	59	2	DOID:2671 (is_implicated_in)
Disease	Lynch syndrome (is_implicated_in)	TGFBR1 ACVR2A	1.05e-03	24	59	2	DOID:3883 (is_implicated_in)
Disease	Hypertrophic obstructive cardiomyopathy	SCO2 RASSF1	1.14e-03	25	59	2	C4551472
Disease	proline measurement	KCNQ5 PRODH	1.24e-03	26	59	2	EFO_0009773
Disease	Micronuclei, Chromosome-Defective	RASSF1 XRCC1	1.24e-03	26	59	2	C1449861
Disease	Micronuclei, Genotoxicant-Induced	RASSF1 XRCC1	1.24e-03	26	59	2	C1449862
Disease	lysophosphatidylethanolamine 20:4 measurement	CACNA1I FBXO33	1.54e-03	29	59	2	EFO_0010370
Disease	Child Development Disorders, Specific	KCNQ2 WDFY4	1.54e-03	29	59	2	C0085997
Disease	Child Development Deviations	KCNQ2 WDFY4	1.54e-03	29	59	2	C0085996
Disease	cervical cancer (is_implicated_in)	RASSF1 XRCC1	1.65e-03	30	59	2	DOID:4362 (is_implicated_in)
Disease	Developmental Disabilities	KCNQ2 WDFY4	1.65e-03	30	59	2	C0008073
Disease	heart conduction disease (implicated_via_orthology)	KCNQ5 KCNQ2	1.88e-03	32	59	2	DOID:10273 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
VIAGGICIFWKRQRE	BTNL10	266	A8MVZ5
CLERFRAEEKGWGIR	ASH1L	2146	Q9NR48
VVRWACDRGFRLVGK	CSMD3	2591	Q7Z407
EVKARGRFGCVWKAQ	ACVR2A	196	P27037
GWSLRAAKVVCRQLG	CD5L	166	O43866
RRRGGWTDVLKCVVS	BOK	166	Q9UMX3
FIWGVVRKGLQCARL	RASSF1	71	Q9NS23
VGGQRSERRKWIHCF	GNAQ	206	P50148
VLCGWRGKASIRTFV	NSUN2	676	Q08J23
WTLEFVGKLDERCRR	BEND3	631	Q5T5X7
RAFRCGVGLVRTVEW	KLHL33	236	A6NCF5
VIKRLWRDGGVQACF	GNAI3	126	P08754
WQGRLRFARKPFCVI	KCNQ5	191	Q9NR82
LWDIRRKGCVFRYRG	KATNB1	131	Q9BVA0
NLECLWEKARRGAGR	LMTK3	476	Q96Q04
KCGWFVRELRVEFAA	FBXO33	131	Q7Z6M2
GWRGRLKFARKPFCV	KCNQ2	156	O43526
VLWDLGRDFRCTVGK	KBTBD2	571	Q8IY47
GRILVVRWKAEDCRL	LAGE3	101	Q14657
DCAAVKVFHRPWRRG	LY75	751	O60449
VGGQRDERRKWIQCF	GNAL	211	P38405
EGERCWLGAKVRRPR	PAPPA2	46	Q9BXP8
LCGDVWRETRAKLRG	CACNA1I	621	Q9P0X4
VGGQRSERRKWIHCF	GNA11	206	P29992
REVICTSRDGDKFWR	LSM4	41	Q9Y4Z0
LAGRVVAGRQACRWV	GLIS1	186	Q8NBF1
RKRVGTARCCGELWA	CELSR3	196	Q9NYQ7
GRARCKADFRGQWVL	SCO2	111	O43819
KLIDFGCARRLAWAG	MAP3K19	1201	Q56UN5
REFAERGARKIVLWG	DHRS3	56	O75911
WLDDRKICAIGVRCG	LIPT2	146	A6NK58
RKNEEAAWGPRVCRA	NRAC	21	Q8N912
VAGLRRFGCVVCRWI	PRXL2B	36	Q8TBF2
EVAARRARVVWCAVG	LTF	356	P02788
DAFGRVWDLRTGRCI	PRPF4	386	O43172
LRGDVWRQFVKRFGD	SLC27A2	341	O14975
RAAGRTGWEDLVRKC	NCOA1	281	Q15788
VIRRLWKDGGVQACF	GNAT2	126	P19087
GSCARVAAWGGKLRR	MICU2	6	Q8IYU8
DVELARREGWCFGAK	PRODH	426	O43272
RREGWCFGAKLVRGA	PRODH	431	O43272
RRGEFCIAKFVDGEW	SND1	731	Q7KZF4
GTVAFTWLRRKCGLV	SLC40A1	356	Q9NP59
GWVRKFCGKGIFREI	PLEKHO1	26	Q53GL0
GCKIRVQGDWIRERR	OCRL	81	Q01968
LVFWEIARRCSIGGI	TGFBR1	406	P36897
REEFSRRWCVLGDGV	ARAP1	766	Q96P48
QLLEIKARGRFGCVW	ACVR2B	191	Q13705
IRWRSCKGERNFAER	C12orf76	61	Q8N812
GKRAARKWRCAGQVT	STK35	86	Q8TDR2
GWRGAACDQRVLIVR	TYRP1	116	P17643
KDGWAFGVARESVRR	TRIM7	406	Q9C029
KEVFASWRLRCAERG	SYNGAP1	566	Q96PV0
VGSGGWRFLRIVCKT	SLC27A1	36	Q6PCB7
TGRCIRKELRCDGWA	ST14	461	Q9Y5Y6
TKLLVGDERGRIFCW	WDFY4	3166	Q6ZS81
KEAWDLGVCRDSVRR	TRIM21	351	P19474
DLVRFWVDRRGCLFA	NEURL3	121	Q96EH8
WVDRRGCLFAKVNAG	NEURL3	126	Q96EH8
CRGIKLAVDWFRDRG	ZC3H12D	111	A2A288
LGGRIVRKEWVLDCH	XRCC1	376	P18887
FRCWGRDTFIALRGI	AGL	1096	P35573
AGLIKIRGDRCWRDL	LMF1	221	Q96S06